HomeALPMF • OTCMKTS
add
Astellas Pharma Inc
Nakaraang pagsara
$15.68
Sakop ng araw
$16.00 - $16.34
Sakop ng taon
$8.40 - $17.39
Market cap
4.71T JPY
Average na Volume
2.84K
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Mga Financial
Income Statement
Kita
Net na kita
| (JPY) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 571.21B | 10.40% |
Gastos sa pagpapatakbo | 322.26B | -6.32% |
Net na kita | 100.38B | 202.78% |
Net profit margin | 17.57 | 193.11% |
Kita sa bawat share | — | — |
EBITDA | 183.68B | 45.71% |
Aktuwal na % ng binabayarang buwis | 25.11% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (JPY) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 254.30B | 41.38% |
Kabuuang asset | 3.60T | 4.41% |
Kabuuang sagutin | 1.84T | -6.07% |
Kabuuang equity | 1.76T | — |
Natitirang share | 1.79B | — |
Presyo para makapag-book | 0.02 | — |
Return on assets | 9.54% | — |
Return on capital | 13.89% | — |
Cash Flow
Net change in cash
| (JPY) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 100.38B | 202.78% |
Cash mula sa mga operasyon | 74.17B | 362.82% |
Cash mula sa pag-invest | -15.78B | 48.64% |
Cash mula sa financing | -90.84B | 12.90% |
Net change in cash | -32.76B | 71.04% |
Malayang cash flow | 24.10B | 74.28% |
Tungkol
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Itinatag
Abr 1, 2005
Headquarters
Website
Mga Empleyado
13,643
